IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
about
Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in miceOsteoimmunology: interactions of the bone and immune systemA model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKLOsteoimmunology and the influence of pro-inflammatory cytokines on osteoclastsFunctional Local Renin-Angiotensin System in Human and Rat Periodontal TissueVitamin D and bone health: potential mechanisms.Leukemia inhibitory factor (LIF)Binge alcohol-induced bone damage is accompanied by differential expression of bone remodeling-related genes in rat vertebral boneParathyroid hormone mediates hematopoietic cell expansion through interleukin-6Baicalin downregulates Porphyromonas gingivalis lipopolysaccharide-upregulated IL-6 and IL-8 expression in human oral keratinocytes by negative regulation of TLR signaling.Upregulation of intercellular adhesion molecule 1 and proinflammatory cytokines by the major surface proteins of Treponema maltophilum and Treponema lecithinolyticum, the phylogenetic group IV oral spirochetes associated with periodontitis and endodProinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot footHigh-resolution genome screen for bone mineral density in heterogeneous stock rat.Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiationThe expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.Cytokine-mediated bone destruction in rheumatoid arthritis.Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis.Gene expression profiles in human and mouse primary cells provide new insights into the differential actions of vitamin D3 metabolites.Bone resorption and remodeling in murine collagenase-induced osteoarthritis after administration of glucosamine.The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis.Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritisGlycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways.The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation.Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.Estrogen receptor-α expression in neuronal cells affects bone mass.Effect of TGF-β1 Stimulation on the Secretome of Human Adipose-Derived Mesenchymal Stromal Cells.Crude triterpenoid saponins from Anemone flaccida (Di Wu) exert anti-arthritic effects on type II collagen-induced arthritis in rats.Modifiable risk factors associated with bone deficits in childhood cancer survivors.The role of interleukin 6 in the pathophysiology of rheumatoid arthritisImmunoregulation of bone remodellingThe gut microbiota regulates bone mass in miceJuxtacrine interaction of macrophages and bone marrow stromal cells induce interleukin-6 signals and promote cell migration.Oncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation.Peri-implant crestal bone loss: a putative mechanism.Rheumatic diseases: the effects of inflammation on bone.Effects of growth factors and cytokines on osteoblast differentiation.The role of the receptor activator of nuclear factor-kappaB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism.Bone remodeling in post-menopausal osteoporosis.Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis.Unique Distal Enhancers Linked to the Mouse Tnfsf11 Gene Direct Tissue-Specific and Inflammation-Induced Expression of RANKL.
P2860
Q24642117-6EA560F4-543C-4E72-AB97-C8E84CFAD28BQ24655113-81661B2D-A650-4078-8D7A-EDFB27FBDAEDQ24799036-B6B71317-F072-4D39-9503-D9AD7EDDA6A0Q26828486-A4B08962-6FC0-4D2F-9EA1-1A91C8BE76B1Q27301201-52D5D4CC-D8AD-4AD1-AA17-EF814E4C7412Q27690804-252CEA80-D87E-4E9A-8D60-80CE9DA25317Q28082576-D94D0009-C036-4D69-8088-86F6CE13EF8EQ28566615-7B201CDB-4C8C-404E-BB0A-A270419E9EC6Q28592017-A0085AB6-1A16-4390-8DA9-432404AEB93EQ31109214-9E056AC0-7FCD-4FC5-B5C1-2117E74B2C28Q33558532-E1EADD45-4E4A-4868-8D3E-1F9D059521B5Q33602274-B9DFFE06-F8A6-4FD1-8012-2DA3D9FDDBADQ33817843-A6B68185-D71D-4D84-8B0D-5E78ABD1D3C2Q33946711-2F940CA9-01EE-451A-AFBE-5CD2A9C61668Q34087187-477DA2CD-E785-4423-AAF2-6B9FC94058BAQ34252489-FA5197BE-724D-43B9-BA7C-A59B48FAB236Q34646212-94892728-0232-4D41-9625-78646C7D022BQ35014417-AF4BAF65-3EC1-4D34-BC9F-C36DD9DA42FCQ35092924-37518336-2874-425F-BF95-FB82619DFF2DQ35429154-B7EE7754-E9C3-413E-B83D-85D65CF6F942Q35617594-84072A57-6CB6-4044-9EC4-A37E6C0534A8Q35632149-0FF1FE28-5C43-4417-BFB0-4DF17ACD351BQ35674722-053324EF-1847-41A4-8BA8-D0E7832F7150Q35724900-96215EFF-7931-4B06-8966-A9FBD9BC2AB0Q35734814-73F228E0-6005-451E-A428-1A78BBAD4B10Q35878879-7D7A3AAA-3051-4087-A28D-3F07D1A33C33Q35888963-B57B47C0-8605-48FF-95EA-5DE83A49C8B2Q35959871-C0C96911-41BC-4A3E-AF62-4CD484685625Q36059484-5F24979E-8640-420E-B89D-26C74E0DB70BQ36107934-FBAE3BFA-0714-4020-9B7C-836D1885DCB7Q36153190-35B6FCA2-DE6B-4533-92DA-0CF49A8D9A96Q36262367-4A74A286-3EDD-4E57-8358-A455DBE57E28Q36296474-C12ED273-9736-4737-89DF-731CC5D52CC6Q36307654-850FF5D9-531C-41BC-9E18-D5BE3036CEA6Q36324975-25267EE5-5A14-4B4B-B177-2A169F471F73Q36474269-0C180391-F492-45E0-92EE-2968FD4D7197Q36494408-6A8D0F69-EE49-4200-9417-38F1D20283AEQ36518536-0C2ED232-E773-4782-AD95-20DFC262EF16Q36518539-DC6E40E8-C113-4E0B-A59C-0AF4009539FAQ36521118-61CACB52-A439-48FD-AE3E-34AA283FAD3E
P2860
IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
IL-6, leukemia inhibitory fact ...... NF-kappa B in mouse calvariae.
@en
IL-6, leukemia inhibitory fact ...... NF-kappa B in mouse calvariae.
@nl
type
label
IL-6, leukemia inhibitory fact ...... NF-kappa B in mouse calvariae.
@en
IL-6, leukemia inhibitory fact ...... NF-kappa B in mouse calvariae.
@nl
prefLabel
IL-6, leukemia inhibitory fact ...... NF-kappa B in mouse calvariae.
@en
IL-6, leukemia inhibitory fact ...... NF-kappa B in mouse calvariae.
@nl
P2093
P1476
IL-6, leukemia inhibitory fact ...... NF-kappa B in mouse calvariae.
@en
P2093
Emma Persson
H Herschel Conaway
Py Palmqvist
P304
P356
10.4049/JIMMUNOL.169.6.3353
P407
P50
P577
2002-09-01T00:00:00Z